|
|
|
|
|
|
|
|
|
|
"Unfortunately, although cost and cost-effectiveness are clearly critical considerations, it is important to acknowledge that sometimes the perspective of one highly relevant constituent in this debate has been lost: the patient."
The Economic Value of 'Reassurance' in Oncology
The value of "reassurance" given to an individual patient following a "positive" or "negative" test result that suggests either the absence or lack of progression of a cancer.
If the link below does not open, please copy and past this link into your browser:
http://www.clinicaloncology.com/ViewArticle.aspx?d=Policy+and+Management&d_id=151&i=November+2012&i_id=910&a_id=22158
Clinical Oncology News
http://www.clinicaloncology.com
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.